Close Menu

University of Toronto

The University of Toronto is developing a platform that enables swapping of various sensing technologies that could measure different analytes in a range of applications.

Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.

In a recent study in Blood, the researchers showed that a higher allelic burden after transplantation was associated with higher risk of relapse and mortality.

The team's portable assay uses digital droplet microfluidics to detect cases of measles and rubella in settings that lack a centralized lab.